[SCHEDULE 13G] Performant Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Glazer Capital, LLC and Paul J. Glazer report a 5.82% ownership stake in Performant Healthcare, Inc. The Schedule 13G shows the Reporting Persons jointly beneficially own 4,595,936 shares of common stock (CUSIP 71377E105). All voting and dispositive power over these shares is reported as shared; neither Glazer Capital nor Mr. Glazer claims sole voting or sole dispositive power. The filing states the position was not acquired to change or influence control of the issuer and notes Glazer Capital acts as investment manager for funds and managed accounts that hold the shares.

Positive

• Material disclosure: Reporting Persons crossed the SEC 5% threshold, filing a Schedule 13G for transparency.
• Clear ownership amount: 4,595,936 shares representing 5.82% of common stock are explicitly reported.
• Shared voting/dispositive power disclosed: All voting and disposal authority is reported as shared, clarifying control structure.
• Passive intent stated: Certification indicates the shares were not acquired to change or influence issuer control.

Negative

• None.

Insights

Financial Analyst

TL;DR: A disclosed 5.82% stake by an investment manager is material but presented as passive with shared voting power.

Glazer Capital's reported 4,595,936-share position crosses the 5% SEC disclosure threshold, making it a material ownership disclosure for Performant Healthcare (PHLT). The filing attributes holdings to funds and managed accounts under Glazer Capital's management and reports all voting and dispositive authority as shared rather than sole, which suggests portfolio-level control rather than direct centralized control by an individual. The certification that the stake was not acquired to change or influence control indicates a passive intent under Schedule 13G rules, limiting immediate governance implications while still signaling an institutional investor with meaningful stake size.

Corporate Governance Expert

TL;DR: Disclosure of shared voting power at >5% is meaningful for governance monitoring but not an active takeover signal.

The reported shared voting and dispositive power means multiple managed vehicles collectively hold influence, but no single reporting person claims sole authority. Under governance norms, a 5.82% holder merits attention from the board and other investors for potential engagement or proxy activity, yet the explicit certification of non-control intent aligns this filing with passive investor status. Stakeholders should note the managing member, Paul J. Glazer, is identified, which centralizes accountability for future communications without implying immediate control actions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PERFORMANT HEALTHCARE, INC.

(Name of Issuer)

Common Stock, par value $.0001 per share

(Title of Class of Securities)

71377E105

(CUSIP Number)

08/14/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 71377E105

1

Names of Reporting Persons

Glazer Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,595,936.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,595,936.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,595,936.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.82 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. 71377E105

1

Names of Reporting Persons

Paul J. Glazer

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,595,936.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,595,936.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,595,936.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.82 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PERFORMANT HEALTHCARE, INC.
(b)	Address of issuer's principal executive offices: 900 SOUTH PINE ISLAND ROAD, SUITE 150, PLANTATION, FL, 33324
Item 2.
(a)	Name of person filing: This statement is filed by: (i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and (ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock (as defined in Item 2(d)) reported herein.
(b)	Address or principal business office or, if none, residence: The address of the business office of each of the Reporting Persons is 250 West 55th Street, Suite 30A, New York, New York 10019.
(c)	Citizenship: Glazer Capital is a Delaware limited liability company. Mr. Glazer is a United States citizen.
(d)	Title of class of securities: Common Stock, par value $.0001 per share
(e)	CUSIP No.: 71377E105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,595,936
(b)	Percent of class: 5.82%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 4,595,936
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 4,595,936
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. See Item 2.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Glazer Capital, LLC

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer, Managing Member
Date:	08/21/2025

Paul J. Glazer

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer
Date:	08/21/2025

FAQ

What stake does Glazer Capital report in Performant Healthcare (PHLT)?

The filing reports 4,595,936 shares, equal to 5.82% of PHLT's common stock.

Who else is named in the Schedule 13G for PHLT besides Glazer Capital?

Paul J. Glazer is also named; he is the Managing Member of Glazer Capital and is reported with the same 4,595,936-share beneficial ownership.

Does Glazer Capital claim sole voting or dispositive power over these PHLT shares?

No. The filing reports 0 sole voting power and 4,595,936 shared voting power, and similarly for dispositive power.

Did the filers state an intent to influence control of Performant Healthcare?

The certification states the securities were not acquired to change or influence control and are held passively under Schedule 13G.

What address is listed for the Reporting Persons in the PHLT filing?

The business office address for the Reporting Persons is listed as 250 West 55th Street, Suite 30A, New York, NY 10019.